Starch-mediated synthesis of chitosan/silver nanocomposites for antibacterial, antibiofilm and wound healing applications

Muneeswaran, Thillaichidambaram; Maruthupandy, Muthuchamy; Mary, Aarcha Shanmugha; Vennila, Thirumalaiswamy; Rajaram, Kaushik; Ramakritinan, C.M.; Quero, Franck

doi:10.1016/j.jddst.2023.104424

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

2025

Publication Types

Select...

Article4

Other1

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 5 publications

References 47 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Biomedical Applications of Starch

Hussain,

Khan,

Annu

et al. 2024

Biopolymers for Biomedical Applications

View full text Add to dashboard Cite

Biomedical Applications of Starch

Hussain,

Khan,

Annu

et al. 2024

Biopolymers for Biomedical Applications

View full text Add to dashboard Cite

In‐situ reduction method to build Chitosan@silver nanoparticles and its application for bis(2‐hydroxyethyl) terephthalate‐based polyurethane composite films with excellent antibacterial and mechanical properties

Li,

He,

Liang

et al. 2024

Polymer Composites

View full text Add to dashboard Cite

Herein, an efficient and rapid one‐step approach to construct CS@Ag nanohybrids through in‐situ reduction of AgNO3 with L‐ascorbic acid using chitosan (CS) as carrier only at room temperature was presented. Novel polyurethane/CS@Ag composite films with remarkable properties were fabricated via the reaction of CS@Ag nanohybrid as an antibacterial and reinforcing agent with bis(2‐hydroxyethyl) terephthalate (BHET)‐based polyurethane. With the increase of CS@Ag content, the antibacterial rate for polyurethane against Staphylococcus aureus and Escherichia coli increases. The antibacterial rate of polyurethane with 20 phr CS@Ag against S. aureus is 85.5%, and that containing 30 phr CS@Ag against E. coli is 94.9%. Thereby, the synergistic effect of CS and Ag can effectively improve the antibacterial rate of polyurethane. Meanwhile, the bond strength and tensile strength of polyurethane containing 20 phr CS@Ag are up to 8.72 MPa (improved by 74.3%) and 20.1 MPa (enhanced by 130.5%), respectively. Indeed, this work may unlock new possibilities for developing antibacterial and enhanced polyurethanes, which are expected to applied in the medical devices, food packaging, and automotive industries.Highlights CS@Ag was efficiently fabricated by in‐situ reduction via a one‐step approach. BHET is used as a novel chain extender for PU. CS@Ag is able to fully exert the synergistic effect of CS and Ag. CS@Ag endows PU with high strength and excellent antimicrobial properties.

show abstract